Lifeline Biotechnologies, Inc. (LLBO)

Market Cap	3.04M +600.0%
Revenue (ttm)	n/a
Net Income	-574.27K
EPS	-0.00
Shares Out	4.35B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	28,000
Open	0.0005
Previous Close	0.0007
Day's Range	0.0005 - 0.0005
52-Week Range	0.000001 - 0.0013
Beta	297.79
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Lifeline Biotechnologies

Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of t...

• Industry: Shell Companies
• Sector: Financials
• Founded: 1981
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: LLBO

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 31, 2026

Data Sources Report a data error